You have 9 free searches left this month | for more free features.

Multi-Purpose Solution

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractive Ametropia Trial (BL-3100-NBR03 multi-purpose solution, renu® Advanced Formula multi-purpose solution)

Not yet recruiting
  • Refractive Ametropia
  • BL-3100-NBR03 multi-purpose solution
  • renu® Advanced Formula multi-purpose solution
  • (no location specified)
Sep 30, 2022

Refractive Errors Trial in Maitland (LID018869+RepleniSH, LID018869+Biotrue, Biofinity+RepleniSH)

Completed
  • Refractive Errors
  • LID018869+RepleniSH
  • +3 more
  • Maitland, Florida
    Alcon Investigator 6565
May 3, 2022

Myopia, Hyperopia Trial in United Kingdom, United States (Test solution, Control solution)

Completed
  • Myopia
  • Hyperopia
  • Test solution
  • Control solution
  • Sarasota, Florida
  • +10 more
Mar 2, 2021

Healthy Contact Lens Wearers Trial in Fort Worth (Alcon MPDS, ReNu Fresh MPS)

Completed
  • Healthy Contact Lens Wearers
  • Alcon MPDS
  • ReNu Fresh MPS
  • Fort Worth, Texas
    Contact Alcon Call Center for Trial Locations
Sep 1, 2020

Myopia Trial in Joyo-shi, Kameoka, Osaka-shi (Bioclean MPS VII, Aosept Clearcare, comfilcon A)

Completed
  • Myopia
  • Bioclean MPS VII
  • +2 more
  • Joyo-shi, Kyoto-fu, Japan
  • +2 more
Aug 4, 2020

Refractive Errors Trial in Maitland, Bloomington, Memphis (Lehfilcon A contact lenses, Comfilcon A contact lenses, Multi-purpose

Completed
  • Refractive Errors
  • Lehfilcon A contact lenses
  • +2 more
  • Maitland, Florida
  • +2 more
Apr 22, 2021

Myopia Trial in Hsinchu (41% Silicone Hydrogel Soft Contact Lenses(SHSCL), ACUVUE® VITA™ (senofilcon C) Brand (Soft) Contact

Recruiting
  • Myopia
  • 41% Silicone Hydrogel Soft Contact Lenses(SHSCL)
  • +3 more
  • Hsinchu, Taiwan
    ApexLens Co., Ltd.
Feb 23, 2021

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Diabetic Ketoacidosis Trial in St Leonards, Redcliffe (Plasma-Lyte 148, 0.9% sodium chloride)

Not yet recruiting
  • Diabetic Ketoacidosis
  • Plasma-Lyte 148
  • 0.9% sodium chloride
  • St Leonards, New South Wales, Australia
  • +1 more
Feb 28, 2023

Elderly, Quality of Life, Physical Activity Trial (multi purpose activities)

Completed
  • Elderly
  • +2 more
  • multi purpose activities
  • (no location specified)
May 12, 2022

Potential Chemoprevention Drugs in Recurrent Hepatocellular

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Surgery
  • No intervention for research purpose
  • Taichung, Taiwan
    China Medical University Hospital, Department of Surgery
Aug 5, 2023

Dry Eye Disease Trial (KIO-101)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Nov 17, 2022

Dry Eye Disease Trial (OK-101, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Mar 8, 2023

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

Not yet recruiting
  • Healthy Subject
  • GS3-007 oral liquid
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023

Complex Perianal Fistulas Trial in Changsha (Human TH-SC01 Cell Injection, Saline solution)

Not yet recruiting
  • Complex Perianal Fistulas
  • Human TH-SC01 Cell Injection
  • Saline solution
  • Changsha, Hunan, China
    Xiangya Hospital Central University
Dec 28, 2022

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Rhegmatogenous Retinal Detachment - Macula Off Trial (ONL1204 Ophthalmic Solution, Sham treatment)

Not yet recruiting
  • Rhegmatogenous Retinal Detachment - Macula Off
  • ONL1204 Ophthalmic Solution
  • Sham treatment
  • (no location specified)
Feb 15, 2023

Dry Eye, Dry Eye Syndromes Trial in United States (Vehicle Opthalmic Solution, PL9643 Opthalmic Solution)

Recruiting
  • Dry Eye
  • Dry Eye Syndromes
  • Vehicle Opthalmic Solution
  • PL9643 Opthalmic Solution
  • Newport Beach, California
  • +9 more
Jan 20, 2022

Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Raynham, Massachusetts
    Andover Eye Associates (Raynham)
Aug 2, 2022

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)

Recruiting
  • Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
  • Anchorage, Alaska
  • +1 more
Oct 12, 2023

Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)

Recruiting
  • Open Angle Glaucoma or Ocular Hypertension
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Oct 14, 2022

Dry Eye Trial in United States (0.3% YP-P10 Ophthalmic Solution, 1% YP-P10 Ophthalmic Solution, YP-P10 Placebo Ophthalmic

Recruiting
  • Dry Eye
  • 0.3% YP-P10 Ophthalmic Solution
  • +2 more
  • Phoenix, Arizona
  • +6 more
Jul 15, 2022

Bleeding From Teeth, Bleeding Prophylaxis Trial in Worldwide (Tranexamic acid)

Recruiting
  • Bleeding From Teeth
  • Bleeding Prophylaxis
  • Tranexamic acid
  • Loma Linda, California
  • +18 more
Nov 21, 2023